Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayahuasca vs Esketamine on Experimentally Induced Pain
NCT07910838Phase 1Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ayahuasca in pain (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Subjective pain and Pain tolerance. Started Jun 2023; status: completed.
02
Drugs
ayahuasca
03
Conditions
pain
Beyond the preview
Go deeper on NCT07910838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910838.